Is DEXCOM INC (DXCM) Halal?

NASDAQ Healthcare United States $24.3B
✓ HALAL
Confidence: 95/100
DEXCOM INC (DXCM) is Halal under all 5 major Shariah screening standards. With a debt ratio of just 5.2% against the AAOIFI threshold of 30%, DEXCOM INC comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Medical Devices), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 5.2%
/ 30%
7.5%
/ 30%
4.9%
/ 30%
2.42%
/ 5%
✓ HALAL
DJIM 5.2%
/ 33%
7.5%
/ 33%
4.9%
/ 33%
2.42%
/ 5%
✓ HALAL
MSCI 21.9%
/ 33%
31.5%
/ 33%
20.3%
/ 33%
2.42%
/ 5%
✓ HALAL
S&P 5.2%
/ 33%
7.5%
/ 33%
4.9%
/ 33%
2.42%
/ 5%
✓ HALAL
FTSE 21.9%
/ 33%
31.5%
/ 33%
20.3%
/ 50%
2.42%
/ 5%
✓ HALAL

Financial Highlights

P/E Ratio
29.8
Forward: 20.8
EPS
$2.09
P/B Ratio
8.7
EV/EBITDA
20.1
EV: $23.4B
Revenue
$4.7B
Growth: 13.1%
Beta
1.5
High volatility
Current Ratio
1.9

Profitability

Gross Margin 60.1%
Operating Margin 25.6%
Net Margin 17.9%
Return on Equity (ROE) 34.5%
Return on Assets (ROA) 8.9%

Cash Flow & Balance Sheet

Operating Cash Flow$1.4B
Free Cash Flow$1.1B
Total Debt$1.4B
Debt-to-Equity50.9
Current Ratio1.9
Total Assets$6.3B

Price & Trading

Last Close$66.09
50-Day MA$70.05
200-Day MA$72.05
Avg Volume5.0M
Beta1.5
52-Week Range
$54.11
$89.98

About DEXCOM INC (DXCM)

CEO
Mr. Jacob Steven Leach
Employees
11,000
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$24.3B
Currency
USD

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Purification Calculator

As a halal stock with 2.42% impermissible income, you need to purify your dividends.

Enter your dividends to calculate purification amount

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is DEXCOM INC (DXCM) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), DEXCOM INC is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is DEXCOM INC's debt ratio?

DEXCOM INC's debt ratio is 5.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 21.9%.

Does DEXCOM INC require dividend purification?

Yes, DEXCOM INC has an impermissible income ratio of 2.42%, which means 2.42% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.

What are DEXCOM INC's key financial metrics?

DEXCOM INC has a market capitalization of $24.3B, trailing P/E ratio of 29.8, and revenue of $4.7B. The company maintains a gross margin of 60.1% and a net margin of 17.9%. Return on equity stands at 34.5%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.